Effects of co-treatment of dextran sulfate sodium and MeIQx on genotoxicity and possible carcinogenicity in the colon of p53-deficient mice.

To investigate the effects of dextran sulfate sodium (DSS) and/or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) on in vivo genotoxicity in the colon, male C57BL/6 p53 (+/+), p53 (+/-) or p53 (-/-) gpt delta mice were twice given 1-week treatment with DSS, 2 weeks apart, and then sacrificed after 2 and 14 weeks. Although colon length was significantly shortened after DSS treatment in all genotypes at each time point, no significant difference in gpt mutant frequency (MF) and tumorigenicity was found between DSS and control groups regardless of genotype. Then, male B6C3F(1) p53 (+/+) or p53 (+/-) gpt delta mice were given DSS as described above and/or fed 300 ppm MeIQx for 7 weeks. Colon length was significantly shortened with DSS in either genotype at weeks 7 and 26, but no effects of co-treatment with MeIQx or p53 deficiency were evident. MeIQx showed a tendency to increase gpt MF in the colon of mice with either genotype, but co-treatment with DSS did not affect these increments. Appreciable incidences of colonic aberrant crypt foci (ACFs) were reported in DSS as well as co-treatment groups of each genotype. Colonic adenomas were observed in co-treatment groups of both genotypes as well as the DSS-only group of p53 (+/+). No effects of the combination of DSS and MeIQx on colon pre- and neoplastic lesions were reported. Our results indicate that MeIQx may take more than 7 weeks to induce genotoxicity in the colon and that the co-treatment of mice did not enhance colon tumorigenicity even in p53-deficient mice.

[1]  L. Samson,et al.  DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. , 2008, The Journal of clinical investigation.

[2]  Tianyu Li,et al.  Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium. , 2007, Carcinogenesis.

[3]  Takuji Tanaka,et al.  Diet supplemented with citrus unshiu segment membrane suppresses chemically induced colonic preneoplastic lesions and fatty liver in male db/db mice , 2007, International journal of cancer.

[4]  S. Hussain,et al.  p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis. , 2006, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[5]  K. Kanki,et al.  Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  T. Sugimura,et al.  Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish , 2004, Cancer science.

[7]  P. Robinson,et al.  Long‐term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue® transgenic mice , 2003, The Journal of pathology.

[8]  K. Kanki,et al.  Low dose genotoxicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in gpt delta transgenic mice. , 2003, Mutation research.

[9]  Takuji Tanaka,et al.  A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate , 2003, Cancer science.

[10]  T. Fujimori,et al.  Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium , 2003, Gut.

[11]  Rashmi Sinha,et al.  An epidemiologic approach to studying heterocyclic amines. , 2002, Mutation research.

[12]  R. Sinha,et al.  Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. , 2002, Mutation research.

[13]  J. Liao,et al.  Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. , 2002, Carcinogenesis.

[14]  Benjamin Geiger,et al.  Down-Regulation of β-Catenin by Activated p53 , 2001, Molecular and Cellular Biology.

[15]  D. W. Green,et al.  Suppression of β-Catenin Inhibits the Neoplastic Growth of APC-Mutant Colon Cancer Cells , 2001 .

[16]  H. Son,et al.  Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis. , 2001, Journal of experimental & clinical cancer research : CR.

[17]  T. Nohmi,et al.  Recent advances in the protocols of transgenic mouse mutation assays. , 2000, Mutation research.

[18]  K Raja,et al.  Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. , 2000, Cancer research.

[19]  T. Sofuni,et al.  In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacI transgenic (Big Blue) mice. , 2000, Mutation research.

[20]  H. Cooper,et al.  Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. , 2000, Carcinogenesis.

[21]  J. Sundberg,et al.  Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[22]  T. Yagi,et al.  Enhanced proliferative potential in culture of cells from p53-deficient mice. , 1993, Oncogene.

[23]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[24]  T. Ohkusa,et al.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice , 1990 .

[25]  N. Gorelick,et al.  Prospects for safety testing: A strategy for the application of transgenic rodent mutagenesis assays , 1996, Environmental and molecular mutagenesis.

[26]  G. Williams,et al.  Absence of genotoxicity of the carcinogenic sulfated polysaccharides carrageenan and dextran sulfate in mammalian DNA repair and bacterial mutagenicity assays. , 1984, Nutrition and cancer.